Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
17 March 1980Website:
http://www.abbott.comNext earnings report:
24 January 2025Last dividends:
15 October 2024Next dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:58:27 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
ABT Latest News
Jim Cramer, the host of 'Mad Money,' examines the legal issues that Abbott Labs is currently dealing with.
Jim Cramer, the host of 'Mad Money,' examines the legal issues that Abbott Labs is currently dealing with.
Abbott Laboratories (ABT) shares are increasing, and Reckitt Benckiser's stocks are also going up in London trading on Friday. This comes after a jury found that both infant formula companies were not responsible for a boy's serious intestinal illness.
A court in St. Louis, Missouri, decided in favor of Abbott Laboratories and Reckitt Benckiser regarding allegations that their special baby formula led to a bowel disease known as NEC in users.
On November 1, 2024, Abbott Laboratories Employees Credit Union (ALECU) announced a data breach that affected the personal information of many customers. This incident has raised worries about the safety of the private data that customers have shared with ALECU.
On Thursday, a jury decided that Abbott and Reckitt's Mead Johnson are not to blame for a young boy's serious intestinal illness. The lawsuit claimed that the companies did not adequately warn about the dangers of their formulas for premature babies. This ruling is a win for the companies after facing significant losses in other similar cases.
Investors searching for health-related stocks to buy and hold should consider this list. The stocks featured here are top performers in the healthcare sector, showing steady growth, strong financial health, great value, and wide market backing.
Investors are positive about Abbott's strong performance in the Diagnostics and Nutrition sectors. However, they are worried about the negative effects of foreign exchange rates.
The ProShares S&P 500 Dividend Aristocrats ETF performed well in the third quarter, increasing by 11.6%. I will share three strategies that could potentially outperform the dividend aristocrat index over time. After monitoring these strategies for 39 months, all three have shown a higher compound annual growth rate (CAGR) than NOBL, along with better dividend yields.
Abbott has started the TEAM-HF trial to enhance results for patients with advanced heart failure.
What type of business is Abbott Laboratories?
Abbott Laboratories is an American chemical-pharmaceutical company. Founded in 1888. Headquarters in Abbott Park, Illinois. The company's profile of activities includes the discovery, development, production, and sale of a wide range of products for the healthcare industry. It focuses on four main areas: pharmaceutical manufacturing (including well-known brands such as Duphaston, Creon, Klacid, and the Influvac flu vaccine), diagnostic equipment, children's and medical nutrition (known brands include the Similac series, PediaSure), and products for vascular therapy.
What sector is Abbott Laboratories in?
Abbott Laboratories is in the Healthcare sector
What industry is Abbott Laboratories in?
Abbott Laboratories is in the Medical Devices industry
What country is Abbott Laboratories from?
Abbott Laboratories is headquartered in United States
When did Abbott Laboratories go public?
Abbott Laboratories initial public offering (IPO) was on 17 March 1980
What is Abbott Laboratories website?
https://www.abbott.com
Is Abbott Laboratories in the S&P 500?
Yes, Abbott Laboratories is included in the S&P 500 index
Is Abbott Laboratories in the NASDAQ 100?
No, Abbott Laboratories is not included in the NASDAQ 100 index
Is Abbott Laboratories in the Dow Jones?
No, Abbott Laboratories is not included in the Dow Jones index
When was Abbott Laboratories the previous earnings report?
No data
When does Abbott Laboratories earnings report?
The next expected earnings date for Abbott Laboratories is 24 January 2025